Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 187.80
+3.55 (1.93%)
At close: Nov 26, 2025
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 14.7 billion as of November 26, 2025. Its market cap has decreased by -8.26% in one year.
Market Cap
14.70B
Enterprise Value
11.85B
Revenue
6.89B
Ranking
n/a
PE Ratio
6.09
Stock Price
187.80
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 14.70B, an increase of 34,314.19%. That is a compound annual growth rate of 24.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 14.42B | -3.06% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | 10.91B | 96.88% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.28T |
| Coloplast | 130.49B |
| Genmab | 123.50B |
| ALK-Abelló | 50.48B |
| Demant | 46.31B |
| H. Lundbeck | 41.97B |
| Zealand Pharma | 38.03B |
| Ambu A/S | 23.50B |